메뉴 건너뛰기




Volumn 16, Issue 4, 2014, Pages 756-770

Mechanistic modeling of monocarboxylate transporter-mediated toxicokinetic/toxicodynamic interactions between γ-hydroxybutyrate and L-lactate

Author keywords

monocarboxylate transporter; toxicodynamics; toxicokinetics; hydroxybutyrate

Indexed keywords

4 HYDROXYBUTYRIC ACID; LACTIC ACID; MONOCARBOXYLATE TRANSPORTER; PLACEBO; COTRANSPORTER; INTRAVENOUS ANESTHETIC AGENT; MONOCARBOXYLATE TRANSPORT PROTEIN 1; OXYBATE SODIUM;

EID: 84903574993     PISSN: None     EISSN: 15507416     Source Type: Journal    
DOI: 10.1208/s12248-014-9593-8     Document Type: Article
Times cited : (9)

References (32)
  • 1
    • 0030895783 scopus 로고    scopus 로고
    • The gamma-hydroxybutyrate signalling system in brain: Organization and functional implications
    • DOI 10.1016/S0301-0082(96)00064-0, PII S0301008296000640
    • Maitre M. The gamma-hydroxybutyrate signalling system in brain: organization and functional implications. Prog Neurobiol. 1997;51:337-61. (Pubitemid 27143802)
    • (1997) Progress in Neurobiology , vol.51 , Issue.3 , pp. 337-361
    • Maitre, M.1
  • 3
    • 79951909577 scopus 로고    scopus 로고
    • Case series of 226 gamma-hydroxybutyrate-associated deaths: Lethal toxicity and trauma
    • Zvosec DL, Smith SW, Porrata T, Strobl AQ, Dyer JE. Case series of 226 gamma-hydroxybutyrate-associated deaths: lethal toxicity and trauma. Am J Emerg Med. 2011;29:319-32.
    • (2011) Am J Emerg Med , vol.29 , pp. 319-332
    • Zvosec, D.L.1    Smith, S.W.2    Porrata, T.3    Strobl, A.Q.4    Dyer, J.E.5
  • 4
    • 6344259978 scopus 로고    scopus 로고
    • Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL): Analysis of overdose cases reported to the Swiss Toxicological Information Centre
    • Liechti ME, Kupferschmidt H. Gamma-hydroxybutyrate (GHB) and gamma-butyrolactone (GBL): analysis of overdose cases reported to the Swiss Toxicological Information Centre. Swiss Med Wkly. 2004;134:534-7. (Pubitemid 39389966)
    • (2004) Swiss Medical Weekly , vol.134 , Issue.35-36 , pp. 534-537
    • Liechti, M.E.1    Kupferschmidt, H.2
  • 5
    • 33745955759 scopus 로고    scopus 로고
    • Transport of gamma-hydroxybutyrate in rat kidney membrane vesicles: Role of monocarboxylate transporters
    • DOI 10.1124/jpet.106.105965
    • Wang Q, Darling IM, Morris ME. Transport of gammahydroxybutyrate in rat kidney membrane vesicles: role of monocarboxylate transporters. J Pharmacol Exp Ther. 2006;318:751-61. (Pubitemid 44061250)
    • (2006) Journal of Pharmacology and Experimental Therapeutics , vol.318 , Issue.2 , pp. 751-761
    • Wang, Q.1    Darling, I.M.2    Morris, M.E.3
  • 6
    • 34547218143 scopus 로고    scopus 로고
    • The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells
    • DOI 10.1124/dmd.107.014852
    • Wang Q, Morris ME. The role of monocarboxylate transporter 2 and 4 in the transport of gamma-hydroxybutyric acid in mammalian cells. Drug Metab Dispos. 2007;35:1393-9. (Pubitemid 47121781)
    • (2007) Drug Metabolism and Disposition , vol.35 , Issue.8 , pp. 1393-1399
    • Wang, Q.1    Morris, M.E.2
  • 7
    • 19444362090 scopus 로고    scopus 로고
    • Renal clearance of gammahydroxybutyric acid in rats: Increasing renal elimination as a detoxification strategy
    • Morris ME, Hu K, Wang Q. Renal clearance of gammahydroxybutyric acid in rats: increasing renal elimination as a detoxification strategy. J Pharmacol Exp Ther. 2005;313:1194- 202.
    • (2005) J Pharmacol Exp Ther , vol.313 , pp. 1194-1202
    • Morris, M.E.1    Hu, K.2    Wang, Q.3
  • 8
    • 0018372970 scopus 로고
    • Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat
    • Lettieri JT, Fung HL. Dose-dependent pharmacokinetics and hypnotic effects of sodium gamma-hydroxybutyrate in the rat. J Pharmacol Exp Ther. 1979;208:7-11. (Pubitemid 9154069)
    • (1979) Journal of Pharmacology and Experimental Therapeutics , vol.208 , Issue.1 , pp. 7-11
    • Lettieri, J.T.1    Fung, H.-L.2
  • 10
    • 4644337779 scopus 로고    scopus 로고
    • GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood-brain barrier
    • DOI 10.1124/jpet.104.069682
    • Bhattacharya I, Boje KM. GHB (gamma-hydroxybutyrate) carrier-mediated transport across the blood- brain barrier. J Pharmacol Exp Ther. 2004;311:92-8. (Pubitemid 39287787)
    • (2004) Journal of Pharmacology and Experimental Therapeutics , vol.311 , Issue.1 , pp. 92-98
    • Bhattacharya, I.1    Boje, K.M.K.2
  • 11
    • 84876493261 scopus 로고    scopus 로고
    • Brain extracellular gamma-hydroxybutyrate concentrations are decreased by L-lactate in rats: Role in the treatment of overdoses
    • Roiko SA, Vijay N, Felmlee MA, Morris ME. Brain extracellular gamma-hydroxybutyrate concentrations are decreased by L-lactate in rats: role in the treatment of overdoses. Pharm Res. 2013;30:1338-48.
    • (2013) Pharm Res , vol.30 , pp. 1338-1348
    • Roiko, S.A.1    Vijay, N.2    Felmlee, M.A.3    Morris, M.E.4
  • 12
    • 76749149579 scopus 로고    scopus 로고
    • Monocarboxylate transporter- mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells
    • Lam WK, Felmlee MA, Morris ME. Monocarboxylate transporter- mediated transport of gamma-hydroxybutyric acid in human intestinal Caco-2 cells. Drug Metab Dispos. 2010;38:441-7.
    • (2010) Drug Metab Dispos , vol.38 , pp. 441-447
    • Lam, W.K.1    Felmlee, M.A.2    Morris, M.E.3
  • 13
    • 84875447051 scopus 로고    scopus 로고
    • Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of gammahydroxybutyrate and gamma-butyrolactone
    • Morse BL, Morris ME. Effects of monocarboxylate transporter inhibition on the oral toxicokinetics/toxicodynamics of gammahydroxybutyrate and gamma-butyrolactone. J Pharmacol Exp Ther. 2013;345:102-10.
    • (2013) J Pharmacol Exp Ther , vol.345 , pp. 102-110
    • Morse, B.L.1    Morris, M.E.2
  • 14
    • 67649397435 scopus 로고    scopus 로고
    • The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): Characterization of SMCT-mediated uptake and inhibition
    • Cui D, Morris ME. The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition. Drug Metab Dispos. 2009;37:1404-10.
    • (2009) Drug Metab Dispos , vol.37 , pp. 1404-1410
    • Cui, D.1    Morris, M.E.2
  • 15
    • 84863936468 scopus 로고    scopus 로고
    • Monocarboxylate transporter inhibition with osmotic diuresis increases γ-hydroxybutyrate renal elimination in humans: A proof-of-concept study
    • Morris ME, Morse BL, Baciewicz GJ, Tessena MM, Acquisto NM, Hutchinson DJ, et al. Monocarboxylate transporter inhibition with osmotic diuresis increases γ-hydroxybutyrate renal elimination in humans: a proof-of-concept study. J Clin Toxicol. 2011;1:1-4.
    • (2011) J Clin Toxicol , vol.1 , pp. 1-4
    • Morris, M.E.1    Morse, B.L.2    Baciewicz, G.J.3    Tessena, M.M.4    Acquisto, N.M.5    Hutchinson, D.J.6
  • 16
    • 84863884501 scopus 로고    scopus 로고
    • gamma-Hydroxybutyrate (GHB)-induced respiratory depression: Combined receptortransporter inhibition therapy for treatment in GHB overdose
    • Morse BL, Vijay N, Morris ME. gamma-Hydroxybutyrate (GHB)-induced respiratory depression: combined receptortransporter inhibition therapy for treatment in GHB overdose. Mol Pharmacol. 2012;82:226-35.
    • (2012) Mol Pharmacol , vol.82 , pp. 226-235
    • Morse, B.L.1    Vijay, N.2    Morris, M.E.3
  • 17
    • 0029797632 scopus 로고    scopus 로고
    • Effects of sodium lactate on ventilation and acid-base balance in healthy humans
    • Tappy L, Cayeux MC, Chiolero R. Effects of sodium lactate on ventilation and acid - base balance in healthy humans. Clin Physiol. 1996;16:393-401. (Pubitemid 26318539)
    • (1996) Clinical Physiology , vol.16 , Issue.4 , pp. 393-401
    • Tappy, L.1    Cayeux, M.-C.2    Chiolero, R.3
  • 18
    • 77955979548 scopus 로고    scopus 로고
    • Mechanistic toxicokinetic model for gamma-hydroxybutyric acid: Inhibition of active renal reabsorption as a potential therapeutic strategy
    • Felmlee MA, Wang Q, Cui D, Roiko SA, Morris ME. Mechanistic toxicokinetic model for gamma-hydroxybutyric acid: inhibition of active renal reabsorption as a potential therapeutic strategy. AAPS J. 2010;12:407-16.
    • (2010) AAPS J , vol.12 , pp. 407-416
    • Felmlee, M.A.1    Wang, Q.2    Cui, D.3    Roiko, S.A.4    Morris, M.E.5
  • 19
    • 33847134473 scopus 로고    scopus 로고
    • Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: Effects on extracellular dopamine
    • Raybon JJ, Boje KM. Pharmacokinetics and pharmacodynamics of gamma-hydroxybutyric acid during tolerance in rats: effects on extracellular dopamine. J Pharmacol Exp Ther. 2007;320:1252- 60.
    • (2007) J Pharmacol Exp Ther , vol.320 , pp. 1252-1260
    • Raybon, J.J.1    Boje, K.M.2
  • 21
    • 0029670749 scopus 로고    scopus 로고
    • gamma-Butyrolactoneinduced absence-like seizures increase nuclear CRE- and AP-1 DNA-binding activities in mouse brain
    • Ishige K, Aizawa M, Ito Y, Fukuda H. gamma-Butyrolactoneinduced absence-like seizures increase nuclear CRE- and AP-1 DNA-binding activities in mouse brain. Neuropharmacology. 1996;35:45-55.
    • (1996) Neuropharmacology , vol.35 , pp. 45-55
    • Ishige, K.1    Aizawa, M.2    Ito, Y.3    Fukuda, H.4
  • 22
    • 84455174556 scopus 로고    scopus 로고
    • Brain uptake of the drug of abuse gamma-hydroxybutyric acid in rats
    • Roiko SA, Felmlee MA, Morris ME. Brain uptake of the drug of abuse gamma-hydroxybutyric acid in rats. Drug Metab Dispos. 2012;40:212-8.
    • (2012) Drug Metab Dispos , vol.40 , pp. 212-218
    • Roiko, S.A.1    Felmlee, M.A.2    Morris, M.E.3
  • 23
    • 0029117415 scopus 로고
    • Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids
    • Tamai I, Takanaga H, Maeda H, Sai Y, Ogihara T, Higashida H, et al. Participation of a proton-cotransporter, MCT1, in the intestinal transport of monocarboxylic acids. Biochem Biophys Res Commun. 1995;214:482-9.
    • (1995) Biochem Biophys Res Commun , vol.214 , pp. 482-489
    • Tamai, I.1    Takanaga, H.2    Maeda, H.3    Sai, Y.4    Ogihara, T.5    Higashida, H.6
  • 25
    • 54049157907 scopus 로고    scopus 로고
    • Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice
    • Frank H, Groger N, Diener M, Becker C, Braun T, Boettger T. Lactaturia and loss of sodium-dependent lactate uptake in the colon of SLC5A8-deficient mice. J Biol Chem. 2008;283:24729-37.
    • (2008) J Biol Chem , vol.283 , pp. 24729-24737
    • Frank, H.1    Groger, N.2    Diener, M.3    Becker, C.4    Braun, T.5    Boettger, T.6
  • 26
    • 84885852231 scopus 로고    scopus 로고
    • Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells
    • Draoui N, Schicke O, Fernandes A, Drozak X, Nahra F, Dumont A, et al . Synthesis and pharmacological evaluation of carboxycoumarins as a new antitumor treatment targeting lactate transport in cancer cells. Bioorg Med Chem. 2013;21:7107-17.
    • (2013) Bioorg Med Chem , vol.21 , pp. 7107-7117
    • Draoui, N.1    Schicke, O.2    Fernandes, A.3    Drozak, X.4    Nahra, F.5    Dumont, A.6
  • 28
    • 0023750861 scopus 로고
    • The kinetics of transport of lactate and pyruvate into rat hepatocytes. Evidence for the presence of a specific carrier similar to that in erythrocytes
    • Edlund GL, Halestrap AP. The kinetics of transport of lactate and pyruvate into rat hepatocytes. Evidence for the presence of a specific carrier similar to that in erythrocytes. Biochem J. 1988;249:117-26.
    • (1988) Biochem J , vol.249 , pp. 117-126
    • Edlund, G.L.1    Halestrap, A.P.2
  • 29
    • 0022501687 scopus 로고
    • Inhibition of lactate removal by ketone bodies in rat liver. Evidence for a quantitatively important role of the plasma membrane lactate transporter in lactate metabolism
    • Metcalfe HK, Monson JP, Welch SG, Cohen RD. Inhibition of lactate removal by ketone bodies in rat liver. Evidence for a quantitatively important role of the plasma membrane lactate transporter in lactate metabolism. J Clin Invest. 1986;78:743-7. (Pubitemid 16024810)
    • (1986) Journal of Clinical Investigation , vol.78 , Issue.3 , pp. 743-747
    • Metcalfe, H.K.1    Monson, J.P.2    Welch, S.G.3    Cohen, R.D.4
  • 30
    • 84455171517 scopus 로고    scopus 로고
    • gamma-Hydroxybutyrate blood/plasma partitioning: Effect of physiologic pH on transport by monocarboxylate transporters
    • Morse BL, Felmlee MA, Morris ME. gamma-Hydroxybutyrate blood/plasma partitioning: effect of physiologic pH on transport by monocarboxylate transporters. Drug Metab Dispos. 2012;40:64-9.
    • (2012) Drug Metab Dispos , vol.40 , pp. 64-69
    • Morse, B.L.1    Felmlee, M.A.2    Morris, M.E.3
  • 31
    • 84879415192 scopus 로고    scopus 로고
    • Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: The ITC evidence-based position
    • Kalvass JC, Polli JW, Bourdet DL, Feng B, Huang SM, Liu X, et al. Why clinical modulation of efflux transport at the human blood-brain barrier is unlikely: the ITC evidence-based position. Clin Pharmacol Ther. 2013;94:80-94.
    • (2013) Clin Pharmacol Ther , vol.94 , pp. 80-94
    • Kalvass, J.C.1    Polli, J.W.2    Bourdet, D.L.3    Feng, B.4    Huang, S.M.5    Liu, X.6
  • 32
    • 77952386385 scopus 로고    scopus 로고
    • Concentrationeffect relationships for the drug of abuse gamma-hydroxybutyric acid
    • Felmlee MA, Roiko SA, Morse BL, Morris ME. Concentrationeffect relationships for the drug of abuse gamma-hydroxybutyric acid. J Pharmacol Exp Ther. 2010;333:761-71. Drug Abuse
    • (2010) J Pharmacol Exp Ther , vol.333 , pp. 761-771
    • Felmlee, M.A.1    Roiko, S.A.2    Morse, B.L.3    Morris, M.E.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.